Biotech Stocks to Buy: INSYS Therapeutics (INSYS)
INSYS Therapeutics (INSY) is a biotech company that focuses on developing pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. Their products include drugs that help patients deal with pain form the disease and help alleviate nausea and pain from chemotherapy. The company reported earnings this week and both profits and sales have exploded higher.
New prescriptions for Subsys, a drug used to alleviate breakthrough pain for cancer patients, was the leading reason for the excellent performance. The company has a strong pipeline as well and expects to file at least New Drug Application and at least four Investigational New Drug applications in 2014. Portfolio Grader upgraded the stock back in August and this biotechnology stock is still a strong buy based on the superior fundamental.